Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Paychex, Inc. (PAYX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs Paychex, Inc. — how do they compare? Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B), while Paychex, Inc. trades at $108.92 (market cap $37.82B). The key difference: Paychex, Inc. is far larger — about 4.5× Hinge Health Inc. Class A Common Stock's market cap, and Paychex, Inc. pays a 4.48% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Paychex, Inc. for 56 Days on average.
| HNGE | PAYX | |
|---|---|---|
Market Cap | $8.48B | $37.82B |
Volume | 879,799 | 2,018,238 |
Sector | Health | Industrials |
52-Week High | $105.14 | $127.54 |
52-Week Low | $31.17 | $85.57 |
Typical Hold Time | 0 Days | 56 Days |
Enterprise Value | $8.10B | $41.51B |
Dividend Yield | — | 4.48% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Paychex (PAYX) trades at $108.37, up 3.56% today, with mixed technical signals showing bullish overall momentum but bearish moving averages. The company maintains strong fundamentals with consistent earnings beats, including Q2 2026 EPS of $1.34 beating $1.32 estimates, and robust profitability metrics including 27.35% net income margin and 47.06% ROE. Recent news highlights dividend safety concerns despite the company's 5-star rating on Newsweek's America's Greatest Companies 2026 list.
Outlook remains cautiously optimistic with analyst consensus target of $111 suggesting modest upside, though high valuation multiples (P/E 21.08, P/S 5.77) and competitive pressures in payroll services present risks. The stock offers income potential with recent $1.19 dividend, but investors should monitor PEO segment performance and labor market trends affecting small business clients.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About Paychex, Inc.
Paychex is a leading provider of payroll, human capital management, and insurance solutions servicing small and midsize clients primarily in the United States. The company, established in 1979, services over 730,000 clients and pays over 1 in 12 U.S. private-sector workers. Alongside its traditional payroll services, Paychex offers HCM solutions such as benefits administration and time and attendance software, as well as human resources outsourcing and insurance agency services.
Read more on PAYX →
